Evidence map›Paper›PMID 32771575›Full record

ArticleJACC. Cardiovascular imaging2020

Prognostic Value of Stress CMR Perfusion Imaging in Patients With Reduced Left Ventricular Function.

Yin Ge, Panagiotis Antiochos, Kevin Steel, Scott Bingham, Shuaib Abdullah, Yi-Yun Chen, J Ronald Mikolich, Andrew E Arai, W Patricia Bandettini, Sujata M Shanbhag and 13 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in JACC. Cardiovascular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03192891 (Stress CMR Perfusion Imaging in the United States), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03192891 completednot on this map

Stress CMR Perfusion Imaging in the United States (SPINS) Study. A Society for Cardiovascular Magnetic Resonance (SCMR) Registry Study

TypeobservationalSponsorSociety for Cardiovascular Magnetic ResonanceRan2016 to 2019Enrolled2,349ConditionsMyocardial IschemiaArmsStress cardiac magnetic resonance (CMR) perfusion imaging
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Cardiac Magnetic Resonance Imaging in Heart Failure.Cardiovascular innovations and applications · 2024
    Article
  12. The Society for Cardiovascular Magnetic Resonance Registry at 150,000.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2024
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 16 institutions in 3 countries.

Yin GeNoninvasive Cardiovascular Imaging Section, Cardiovascular Division of Department of Medicine and Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
Panagiotis AntiochosNoninvasive Cardiovascular Imaging Section, Cardiovascular Division of Department of Medicine and Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
Kevin SteelCardiology Division, San Antonio Military Medical Center, San Antonio, Texas.
Scott BinghamRevere Health, Provo, Utah.
Shuaib AbdullahVeteran Administration North Texas Healthcare System, University of Texas Southwestern Medical Center, Dallas, Texas.
Yi-Yun ChenNoninvasive Cardiovascular Imaging Section, Cardiovascular Division of Department of Medicine and Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.
J Ronald MikolichDepartment of Cardiovascular Medicine, Sharon Regional Health System, Sharon, Pennsylvania.
Andrew E AraiNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
W Patricia BandettiniNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Sujata M ShanbhagNational Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Amit R PatelCardiology Division, Department of Medicine, University of Chicago, Chicago, Illinois.
Afshin Farzaneh-FarDivision of Cardiology, University of Illinois at Chicago, Chicago, Illinois.
John F HeitnerDivision of Cardiology, New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn, New York.
Chetan ShenoyCardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota.
Steve W LeungGill Heart and Vascular Institute, Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky.
Jorge A GonzalezDivision of Cardiology and Radiology, Scripps Clinic, La Jolla, California.
Dipan J ShahHouston Methodist DeBakey Heart & Vascular Center, Houston, Texas.
Subha V RamanDivision of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
Victor A FerrariCardiovascular Division, Perelman School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Jeanette Schulz-MengerWorking Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, Berlin, and Helios Clinics, Berlin, Germany.
Matthias StuberDepartment of Radiology, University Hospital and University of Lausanne, Lausanne, Switzerland.
Orlando P SimonettiDivision of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
Raymond Y KwongNoninvasive Cardiovascular Imaging Section, Cardiovascular Division of Department of Medicine and Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: rykwong@bwh.harvard.edu.
Brigham and Women's Hospital · USNational Institutes of Health · USThe Ohio State University · USBrooke Army Medical Center · USHelios Hospital Berlin-Buch · DEHospital of the University of Pennsylvania · USHouston Methodist · USNewYork–Presbyterian Brooklyn Methodist Hospital · USRegional Health · USScripps Clinic · USSouthwestern Medical Center · USUniversity of Chicago · USUniversity of Illinois Chicago · USUniversity of Kentucky · USUniversity of Lausanne · CHUniversity of Minnesota Medical Center · US

Funding

Technical Development of Diagnostic Cardiovascular MRIZIAHL004607 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW · 2009 to 2020
$25.3M
Quantification of Myocardial PerfusionZIAHL006137 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI ARAI, ANDREW · 2011 to 2020
$9.4M
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related CardiotoxicityK23HL132011 · NHLBI · UNIVERSITY OF MINNESOTA · PI SHENOY, CHETAN N · 2016 to 2020
$884k
Intramural NIH HHS ZIA HL004607Intramural NIH HHS ZIA HL006137NHLBI NIH HHS K23 HL132011
6 · The paper itself

Abstract

objectivesThe aim of this study was to investigate the prognostic value of stress cardiac magnetic resonance imaging (CMR) in patients with reduced left ventricular (LV) systolic function.

backgroundPatients with ischemic cardiomyopathy are at risk from both myocardial ischemia and heart failure. Invasive testing is often used as the first-line investigation, and there is limited evidence as to whether stress testing can effectively provide risk stratification.

methodsIn this substudy of a multicenter registry from 13 U.S. centers, patients with reduced LV ejection fraction (<50%), referred for stress CMR for suspected myocardial ischemia, were included. The primary outcome was cardiovascular death or nonfatal myocardial infarction. The secondary outcome was a composite of cardiovascular death, nonfatal myocardial infarction, hospitalization for unstable angina or congestive heart failure, and unplanned late coronary artery bypass graft surgery.

resultsAmong 582 patients (mean age 62 ± 12 years, 34% women), 40% had a history of congestive heart failure, and the median LV ejection fraction was 39% (interquartile range: 28% to 45%). At median follow-up of 5.0 years, 97 patients had experienced the primary outcome, and 182 patients had experienced the secondary outcome. Patients with no CMR evidence of ischemia or late gadolinium enhancement (LGE) experienced an annual primary outcome event rate of 1.1%. The presence of ischemia, LGE, or both was associated with higher event rates. In a multivariate model adjusted for clinical covariates, ischemia and LGE were independent predictors of the primary (hazard ratio [HR]: 2.63; 95% confidence interval [CI]: 1.68 to 4.14; p < 0.001; and HR: 1.86; 95% CI: 1.05 to 3.29; p = 0.03) and secondary (HR: 2.14; 95% CI: 1.55 to 2.95; p < 0.001; and HR 1.70; 95% CI: 1.16 to 2.49; p = 0.007) outcomes. The addition of ischemia and LGE led to improved model discrimination for the primary outcome (change in C statistic from 0.715 to 0.765; p = 0.02). The presence and extent of ischemia were associated with higher rates of use of downstream coronary angiography, revascularization, and cost of care spent on ischemia testing.

conclusionsStress CMR was effective in risk-stratifying patients with reduced LV ejection fractions. (Stress CMR Perfusion Imaging in the United States [SPINS] Study; NCT03192891).

Indexed as

Ventricular Function, LeftAgedContrast MediaFemaleGadoliniumHumansMagnetic Resonance ImagingMagnetic Resonance Imaging, CineMaleMiddle AgedPerfusion ImagingPredictive Value of TestsPrognosisRisk FactorsContrast MediaGadoliniumcardiomyopathyprognosisstress cardiac MRI

Identifiers

PMID32771575
PMCPMC10823343
OpenAlexW3047285383

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.